Five PFF Scholars Receive $100K Grants to Advance Pulmonary Fibrosis Research
Five PFF Scholars will each receive a $100,000 research grant over two years to improve the understanding of pulmonary fibrosis and advance successful treatments.
Five PFF Scholars will each receive a $100,000 research grant over two years to improve the understanding of pulmonary fibrosis and advance successful treatments.
Five PFF Scholars will each receive a $100,000 research grant over two years to improve the understanding of pulmonary fibrosis and advance successful treatments.
Read MoreThe Pulmonary Fibrosis Foundation and Pulmonary Hypertension Association have developed a position statement that addresses gaps in the diagnosis and treatment of patients living with pulmonary hypertension related to interstitial lung disease.
Read MoreThe Pulmonary Fibrosis Foundation announced that seven medical centers have joined the PFF Care Center Network as clinical associate members, a new membership option.Â
Read MoreThe Pulmonary Fibrosis Foundation announced Franck Rahaghi, MD, MHS, FCCP, as its incoming president, CEO, and chief medical officer, effective Sept 15.
Read MoreThe medical advisory board of the Pulmonary Fibrosis Foundation issued a position statement on non-prescription supplemental oxygen.
Read MoreImportant research results from five studies examining access to care and outcomes for patients living with pulmonary fibrosis and interstitial lung disease (ILD) are being presented at ATS 2022.
Read MoreThe Pulmonology Advisor interviewed experts to learn about how the Pulmonary Fibrosis Foundation’s PFF Care Center Network can advance research.
Read MoreSeptember is Pulmonary Fibrosis Awareness Month. This year the Pulmonary Fibrosis Foundation is celebrating PF Heroes who are raising awareness of the disease.
Read MoreThe Pulmonary Fibrosis Foundation’s recent PFF Summit has announced winners for its poster sessions.
Read MoreThe PF Foundation has launched a new PF Drug Development Pipeline tool to help the pulmonary fibrosis community search for different treatment options.
Read MoreThe Pulmonary Fibrosis Foundation strongly cautions patients with PF against using stem cell treatments outside of an approved clinical trial.
Read MoreThe guide provides patients and families with up-to-date information about pulmonary fibrosis and treatment options.
Read MoreThe Pulmonary Fibrosis Foundation is expanding its Patient Care Network and Patient Registry, which it formed in late 2013 to improve the quality of life for patients with all types of pulmonary fibrosis, including idiopathic pulmonary fibrosis.
Read MoreIn September, the Food and Drug Administration will host a meeting on patient-focused drug treatment of idiopathic pulmonary fibrosis (IPF), according to an announcement from the Pulmonary Fibrosis Foundation.
Read More